Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells

Blood. 1995 Nov 1;86(9):3413-20.

Abstract

A ligand for the tyrosine kinase receptor flt3/flk-2, referred to here as flt3 ligand (flt3L), was recently cloned. The effect of flt3L on purified human CD34+ progenitor cells was examined. flt3 receptor (flt3R) was detected on the surface of human bone marrow cells that were enriched for CD34 expression. The effects of flt3L and the c-kit ligand Steel factor (SLF) on hematopoietic progenitors were compared in clonal colony assays. Both factors synergized with Pixy321 (interleukin-3 [IL-3]-granulocyte-macrophage colony-stimulating factor fusion protein) to induce granulocytic-monocytic (GM) and high proliferative potential (HPP) colonies and synergized with Pixy321 + erythropoietin (EPO) to induce multipotent granulocytic-erythroid-monocytic-megakaryocytic colonies. Although SLF had a potent effect on colony formation of erythroid restricted progenitor cells (burst-forming unit-erythroid), no effect by flt3L was observed. The addition of flt3L to irradiated long-term marrow cultures seeded with CD34+ cells augmented both total and progenitor cell production. Ex vivo expansion studies with isolated CD34+ bone marrow cells from normal donors showed that flt3L alone supported maintenance of both GM and HPP progenitors for 3 to 4 weeks in vitro. The addition of flt3L to a growth factor combination of IL-1 alpha + IL-3 + IL-6 + EPO resulted in a synergistic effect on progenitor cell expansion comparable to that observed with the addition of SLF to IL-1 alpha + IL-3 + IL-6 + EPO. These data show a function for flt3L in the regulation of both primitive multipotent and lineage-committed hematopoietic progenitor cells.

MeSH terms

  • Antigens, CD34
  • Bone Marrow Cells
  • Cell Division / drug effects
  • Colony-Forming Units Assay
  • Drug Synergism
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Hematopoietic Cell Growth Factors / pharmacology
  • Hematopoietic Stem Cells / drug effects*
  • Humans
  • Interleukin-3 / pharmacology
  • Membrane Proteins / pharmacology*
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Proto-Oncogene Proteins / physiology
  • Receptor Protein-Tyrosine Kinases / physiology
  • Recombinant Fusion Proteins / pharmacology
  • Signal Transduction / drug effects*
  • Stem Cell Factor / pharmacology
  • fms-Like Tyrosine Kinase 3

Substances

  • Antigens, CD34
  • Hematopoietic Cell Growth Factors
  • Interleukin-3
  • Membrane Proteins
  • PIXY321 fusion protein, recombinant
  • Proto-Oncogene Proteins
  • Recombinant Fusion Proteins
  • Stem Cell Factor
  • flt3 ligand protein
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • FLT3 protein, human
  • Receptor Protein-Tyrosine Kinases
  • fms-Like Tyrosine Kinase 3